December 16, 2021
Takeda Pharmaceutical said on December 15 that it has built a new manufacturing line for its recently approved Crohn’s disease cell therapy Alofisel (darvadstrocel) at a plant in Osaka, western Japan. In Japan, Alofisel was approved late September for the...read more